CytomX Therapeutics to Report First Quarter 2026 Financial Results on May 7, 2026
Go back to CytomX Therapeutics to Report First Quarter 2026 Financial Results on May 7, 2026| Eaton Vance Dividend Builder Fd Cl C (NASDAQ: CTMX) | Delayed: 3.03 +0.08 (2.71%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $2.95 | 52 Week High | $24.68 | |||
| Open | $2.98 | 52 Week Low | $9.10 | |||
| Day High | $3.08 | P/E | N/A | |||
| Day Low | $2.95 | EPS | $0.00 | |||
| Volume | 3,131,194 | |||||
